Castle Biosciences Announced Publication Of A New Study In Future Oncology Further Substantiating Use Of Its DecisionDx-SCC Test In Guiding Patient Selection And Decision-making Related To The Use Of Art In Patients With High-risk Cutaneous Squamous...
Castle Biosciences Announced Publication Of A New Study In Future Oncology Further Substantiating Use Of Its DecisionDx-SCC Test In Guiding Patient Selection And Decision-making Related To The Use Of Art In Patients With High-risk Cutaneous Squamous...
Castle Biosciences宣佈在未來腫瘤學雜誌上發佈了一項新研究，進一步證實了其DecisionDx-SCC測試在指導高風險皮膚鱗癌患者選型和決策方面的應用
Castle Biosciences Announced Publication Of A New Study In Future Oncology Further Substantiating Use Of Its DecisionDx-SCC Test In Guiding Patient Selection And Decision-making Related To The Use Of Art In Patients With High-risk Cutaneous Squamous Cell Carcinoma
Castle Biosciences宣佈在未來腫瘤學雜誌上發佈了一項新研究，進一步證實了其DecisionDx-SCC測試在指導高風險皮膚鱗癌細胞癌患者的選型和決策方面的應用
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。